Brain, Vol. 124, No. 3, 468-479,
March 2001
© 2001 Oxford University Press
Long-term remyelination after optic neuritis
A 2-year visual evoked potential and psychophysical serial study
1 Departments of Clinical Neurophysiology and 2 Neuro-ophthalmology, The National Hospital for Neurology and Neurosurgery, London, UK
Correspondence to:
Dr S. J. Jones, Department of Clinical Neurophysiology, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK E-mail: sjjones{at}ion.ucl.ac.uk
Thirty-one patients were followed-up, at 3-month intervals for the first year and at 6-month intervals for the second year, after an episode of optic neuritis. The object was to confirm previous evidence for a progressive shortening of visual evoked potential (VEP) latencies and to determine whether this is associated with any change in the clinical ocular examination, visual fields or contrast sensitivity. VEP latencies were found to decrease significantly during both the first and (less strikingly) the second year, the most marked changes occurring between 3 and 6 months. Contrast sensitivity improved during the first 9 months, but subsequently tended (non-significantly) to deteriorate. A similarly transient improvement in central visual field sensitivity was seen in a subgroup of patients with clinically overt multiple sclerosis. In the data from the acutely unaffected fellow eyes, no significant changes in VEP parameters or functional indices were observed. The findings extend those of a previous study which showed significant shortening of VEP latencies between 6 months and 3 years without significant functional improvement. Over this period, a significant prolongation of VEP latencies occurred in the asymptomatic fellow eye, accompanied by contrast sensitivity deterioration. Taken in conjunction, the two studies suggest that recovery processes involving remyelination or, possibly, ion channel reorganization proceed for at least 2 years. The concurrent effects of insidious demyelination and/or axonal degeneration (also occurring in the fellow optic nerve) are initially masked by the recovery process, but gradually become more evident. The functional benefits of the long-term recovery process are relatively minor and are usually reversed within a few years. Nevertheless, it is suggested that long-term remyelination may perform an important role in protecting demyelinated axons from degeneration. Understanding the factors which promote long-term remyelination may have significant implications for therapy in multiple sclerosis.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. T. Naismith, N. T. Tutlam, J. Xu, J. B. Shepherd, E. C. Klawiter, S. -K. Song, and A. H. Cross Optical coherence tomography is less sensitive than visual evoked potentials in optic neuritis Neurology, July 7, 2009; 73(1): 46 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Niklas, H Sebraoui, E Hess, A Wagner, and F Then Bergh Outcome measures for trials of remyelinating agents in multiple sclerosis: retrospective longitudinal analysis of visual evoked potential latency Multiple Sclerosis, January 1, 2009; 15(1): 68 - 74. [Abstract] [PDF]
|
|
|
|
 |
|
 F. Di Russo, T. Aprile, G. Spitoni, and D. Spinelli Impaired visual processing of contralesional stimuli in neglect patients: a visual-evoked potential study Brain, March 1, 2008; 131(3): 842 - 854. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Klistorner, S. Graham, C. Fraser, R. Garrick, T. Nguyen, M. Paine, J. O'Day, J. Grigg, H. Arvind, and F. A. Billson Electrophysiological Evidence for Heterogeneity of Lesions in Optic Neuritis Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4549 - 4556. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Kupersmith, R. L. Gal, R. W. Beck, D. Xing, N. Miller, and The Optic Neuritis Study Group Visual function at baseline and 1 month in acute optic neuritis: Predictors of visual outcome Neurology, August 7, 2007; 69(6): 508 - 514. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Trip, P. Schlottmann, S. Jones, W-Y. Li, D. Garway-Heath, A. Thompson, G. Plant, and D. Miller Optic nerve magnetization transfer imaging and measures of axonal loss and demyelination in optic neuritis Multiple Sclerosis, August 1, 2007; 13(7): 875 - 879. [Abstract] [PDF]
|
|
|
|
|
|
K. Korsholm, K. H. Madsen, J. L. Frederiksen, A. Skimminge, and T. E. Lund Recovery from optic neuritis: an ROI-based analysis of LGN and visual cortical areas Brain, May 1, 2007; 130(5): 1244 - 1253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. B. Yang, D. C. Hood, C. Rodarte, X. Zhang, J. G. Odel, and M. M. Behrens Improvement in Conduction Velocity after Optic Neuritis Measured with the Multifocal VEP Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 692 - 698. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S A Trip, P G Schlottmann, S J Jones, D F Garway-Heath, A J Thompson, G T Plant, and D H Miller Quantification of optic nerve head topography in optic neuritis: a pilot study Br. J. Ophthalmol., September 1, 2006; 90(9): 1128 - 1131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Hickman, C. A. M. Wheeler-Kingshott, S. J. Jones, K. A. Miszkiel, G. J. Barker, G. T. Plant, and D. H. Miller Optic Nerve Diffusion Measurement from Diffusion-Weighted Imaging in Optic Neuritis AJNR Am. J. Neuroradiol., April 1, 2005; 26(4): 951 - 956. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Hickman, A. T. Toosy, S. J. Jones, D. R. Altmann, K. A. Miszkiel, D. G. MacManus, G. J. Barker, G. T. Plant, A. J. Thompson, and D. H. Miller A serial MRI study following optic nerve mean area in acute optic neuritis Brain, November 1, 2004; 127(11): 2498 - 2505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Petzold, K Rejdak, and G T Plant Axonal degeneration and inflammation in acute optic neuritis J. Neurol. Neurosurg. Psychiatry, August 1, 2004; 75(8): 1178 - 1180. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Hickman, A. T. Toosy, S. J. Jones, D. R. Altmann, K. A. Miszkiel, D. G. MacManus, G. J. Barker, G. T. Plant, A. J. Thompson, and D. H. Miller Serial magnetization transfer imaging in acute optic neuritis Brain, March 1, 2004; 127(3): 692 - 700. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B Weinstock-Guttman, M Baier, R Stockton, A Weinstock, T Justinger, F Munschauer, C Brownscheidle, J Williams, E Fisher, D Miller, et al. Pattern reversal visual evoked potentials as a measure of visual pathway pathology in multiple sclerosis Multiple Sclerosis, October 1, 2003; 9(5): 529 - 534. [Abstract] [PDF]
|
|
|
|
|
|
L Frisen Spatial vision in visually asymptomatic subjects at high risk for multiple sclerosis J. Neurol. Neurosurg. Psychiatry, August 1, 2003; 74(8): 1145 - 1147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Fuhr, A. Borggrefe-Chappuis, C. Schindler, and L. Kappos Visual and motor evoked potentials in the course of multiple sclerosis Brain, November 1, 2001; 124(11): 2162 - 2168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Does Remyelination After Optic Neuritis Result in Clinical Improvement? Journal Watch Neurology, June 28, 2001; 2001(628): 4 - 4. [Full Text]
|
|